Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas

Objectives: Our aim was to compare the survival between patients with clear cell carcinoma (CC) and patients with endometrioid carcinoma (EC). Methods: Through the population-based Geneva Cancer Registry, we identified 1,380 resident women diagnosed with uterine cancer between 1970 and 2000. We excluded those with papillary serous endometrial carcinoma and uterine sarcomas. We categorized patients as CC (n = 32, 2.8%) or EC (n = 1, 145, 97.2%). Uterine cancer-specific survival rates were calculated by Kaplan-Meier analysis. We used Cox proportional hazards analysis to compare uterine cancer mortality risks between groups, and adjusted these risks for other prognostic factors. Results: CC patients presented with a more advanced stage at diagnosis than EC patients (p = 0.002). Compared to women with EC, women with CC had a significantly greater risk of dying from their disease (hazard ratio [HR] 2.9, 95% confidence interval (95% CI) 1.7-4.9). After adjustment for age, stage and adjuvant chemotherapy, the risk of dying from uterine cancer was still significantly higher for CC patients (HR 2.0, 95% CI 1.2-3.4). By univariate analysis, the risk of dying of endometrial cancer was not significantly higher in CC patients than in patients with poorly-differentiated EC (HR 1.3, 95% CI 0.7-2.3). Conclusion: This population-based investigation shows that patients with CC have a poorer outcome than those with EC. Studies to determine the role of adjuvant treatment in CC patients are needed.

Adjuvant chemotherapy; Endometrioid carcinoma; Clear cell carcinoma; Survival

[1] Creasman W.T., Kohler M.F., Odicino F., Maisonneuve P., Boyle P.: “Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium”. Gynecol. Oncol., 2004, 95, 593.

[2] Hamilton C.A., Cheung M.K., Osann K., Chen L., Teng N.N., Longacre T.A. et al.: “Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers”. Br. J. Cancer, 2006, 13, 642.

[3] Cirisano F.D. Jr, Robboy S.J., Dodge R.K., Bentley R.C., Krigman H.R., Synan I.S. et al.: “The outcome of Stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with EC”. Gynecol. Oncol., 2000, 77, 55.

[4] Webb G.A., Lagios M.D.: “Clear cell carcinoma of the endometrium”. Am. J. Obstet. Gynecol., 1987, 156, 1486.

[5] Carcangiu M.L., Chambers J.T.: “Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival”. Int. J. Gynecol. Pathol., 1995, 14, 30.

[6] Abeler V.M., Vergote I.B., Kjorstad K.E., Trope C.G.: “Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern”. Cancer, 1996, 78, 1740.

[7] Photopulos G.J., Carney C.N., Edelman D.A., Hughes R.R., Fowler W.C. Jr, Walton L.A.: “Clear cell carcinoma of the endometrium”. Cancer, 1979, 43, 1448.

[8] Malpica A., Tornos C., Burke T.W., Silva E.G. et al.: “Low-stage clear-cell carcinoma of the endometrium”. Am. J. Surg. Pathol., 1995, 19, 769.

[9] Murphy K.T., Rotmensch J., Yamada S.D., Mundt A.J.: “Outcome and patterns of failure in pathologic Stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy”. Int. J. Rad. Oncol. Biol. Phys., 2003, 55, 1272.

[10] Alektiar K.M., McKee A., Lin O., Venkatraman E., Zelefsky M.J., McKee B. et al.: “Is there a difference in outcome between Stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?”. Int. J. Rad. Oncol. Biol. Phys., 2002, 54, 79.

[11] Giri P.G., Schneider V., Belgrad R.: “Clear cell carcinoma of the endometrium: An uncommon entity with a favorable prognosis”. Int. J. Radiat. Oncol. Biol. Phys., 1981, 7, 1383.

[12] Bouchardy C.: “Cancer Incidence in Five Continents”. Vol VII. Lyon, France, International Agency for Research on Cancer, 1997, 666.

[13] WHO, ICD-O International Classification of Diseases for Oncology. 1976.

[14] Trope C., Kristensen G.B., Abeler V.M.: “Clear-cell and papillary serous cancer: treatment options”. Best. Pract. Res. Clin. Obstet. Gynaecol., 2001, 15, 433.

[15] Kurman R.J., Scully R.E.: “Clear cell carcinoma of the endometrium: an analysis of 21 cases”. Cancer, 1976, 37, 872.